Skip to main content
. 2020 May 1;21(9):3213. doi: 10.3390/ijms21093213

Figure 5.

Figure 5

Overall survival (OS) of miR-143 high expression group and miR-143 low expression group in TCGA and METABRIC. Only ER positive subgroup demonstrated improved OS. ER+, estrogen receptor positive; HER2, human epidermal growth factor receptor 2; TN, triple negative.